Copper chelation chemistry and its role in copper radiopharmaceuticals.

Overview of attention for article published in Current Pharmaceutical Design, January 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 9 patents

Readers on

mendeley: 161 Mendeley

So far, Altmetric has seen 9 patents that reference this research output.

Radioligands for pretargeted PET imaging and methods of their therapeutic use

Grant US-12734258-B2

United States of America

15 Sep 2026

LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING…

Application EP-4473980-A2

European Patent Office

11 Dec 2024

Tumor and immune cell imaging based on PD-L1 expression

Grant US-11607466-B2

United States of America

21 Mar 2023

Radioligands for pretargeted pet imaging and methods of their therapeutic use

Grant US-11135320-B2

United States of America

05 Oct 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.